BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 1732739)

  • 21. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential induction of NF-kappa B/Rel family proteins during B-cell terminal differentiation.
    Liou HC; Sha WC; Scott ML; Baltimore D
    Mol Cell Biol; 1994 Aug; 14(8):5349-59. PubMed ID: 8035813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cloning of the p50 DNA binding subunit of NF-kappa B: homology to rel and dorsal.
    Ghosh S; Gifford AM; Riviere LR; Tempst P; Nolan GP; Baltimore D
    Cell; 1990 Sep; 62(5):1019-29. PubMed ID: 2203532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of the human P-selectin promoter by Bcl-3 and specific homodimeric members of the NF-kappa B/Rel family.
    Pan J; McEver RP
    J Biol Chem; 1995 Sep; 270(39):23077-83. PubMed ID: 7559449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
    Verma IM; Stevenson JK; Schwarz EM; Van Antwerp D; Miyamoto S
    Genes Dev; 1995 Nov; 9(22):2723-35. PubMed ID: 7590248
    [No Abstract]   [Full Text] [Related]  

  • 26. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
    Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
    J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 65-kDa subunit of human NF-kappa B functions as a potent transcriptional activator and a target for v-Rel-mediated repression.
    Ballard DW; Dixon EP; Peffer NJ; Bogerd H; Doerre S; Stein B; Greene WC
    Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1875-9. PubMed ID: 1542686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RelB, a member of the Rel/NF-kappa B family of transcription factors.
    Ryseck RP; Weih F; Carrasco D; Bravo R
    Braz J Med Biol Res; 1996 Jul; 29(7):895-903. PubMed ID: 9070378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional and physical associations between NF-kappa B and C/EBP family members: a Rel domain-bZIP interaction.
    Stein B; Cogswell PC; Baldwin AS
    Mol Cell Biol; 1993 Jul; 13(7):3964-74. PubMed ID: 8321203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.
    White DW; Pitoc GA; Gilmore TD
    Mol Cell Biol; 1996 Mar; 16(3):1169-78. PubMed ID: 8622661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human RelB (I-Rel) functions as a kappa B site-dependent transactivating member of the family of Rel-related proteins.
    Bours V; Azarenko V; Dejardin E; Siebenlist U
    Oncogene; 1994 Jun; 9(6):1699-702. PubMed ID: 8183565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation.
    Kunsch C; Ruben SM; Rosen CA
    Mol Cell Biol; 1992 Oct; 12(10):4412-21. PubMed ID: 1406630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic analysis of growth inhibition by GAL4-L kappa B-alpha in Saccharomyces cerevisiae.
    Morin PJ; Downs JA; Snodgrass AM; Gilmore TD
    Cell Growth Differ; 1995 Jul; 6(7):789-98. PubMed ID: 7547500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The DNA binding subunit of NF-kappa B is identical to factor KBF1 and homologous to the rel oncogene product.
    Kieran M; Blank V; Logeat F; Vandekerckhove J; Lottspeich F; Le Bail O; Urban MB; Kourilsky P; Baeuerle PA; Israël A
    Cell; 1990 Sep; 62(5):1007-18. PubMed ID: 2203531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
    Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
    Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential interactions of Rel-NF-kappa B complexes with I kappa B alpha determine pools of constitutive and inducible NF-kappa B activity.
    Dobrzanski P; Ryseck RP; Bravo R
    EMBO J; 1994 Oct; 13(19):4608-16. PubMed ID: 7925301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.
    Hrdlicková R; Nehyba J; Bose HR
    J Virol; 1995 Jun; 69(6):3369-80. PubMed ID: 7745683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential nuclear localization of p50, p52, and RelB proteins in human accessory cells of the immune response in situ.
    Feuillard J; Körner M; Israel A; Vassy J; Raphael M
    Eur J Immunol; 1996 Nov; 26(11):2547-51. PubMed ID: 8921937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NF-kappa B: a lesson in family values.
    Thanos D; Maniatis T
    Cell; 1995 Feb; 80(4):529-32. PubMed ID: 7867060
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.